Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT02173080 · ClinicalTrials.gov registry record
Development and Assessment of The Polycystic Liver Disease Questionnaire (PLD-Q).
A clinical trial, sponsored by Mayo Clinic.
- Completed
- Registry status
- 594
- Enrollment target
NCT02173080: Completed study, sponsored by Mayo Clinic.
NCT02173080 is a clinical trial that has completed, run by Mayo Clinic. The registered enrollment target is 594 participants. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT02173080 has completed, sponsored by Mayo Clinic.
- COMPLETED
- Registry status
- 594 participants
- Enrollment target
Study Summary
This Pilot study will enable development \& assessment of a Polycystic Liver Disease-specific patient reported outcomes questionnaire (PLD-Q). Polycystic liver disease (PLD) is characterized by the formation of numerous cysts in the liver, and can lead to severe symptomatic hepatomegaly. It is common in patients with autosomal dominant polycystic liver disease (ADPLD) and autosomal dominant polycystic kidney disease (ADPKD).
Interventions
- OTHER PLD-Q
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 594 participants |
| Start Date | 2014-06 |
| Est. Completion | 2024-03-11 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT02173080
The ClinicalTrials.gov registry entry for NCT02173080 describes a study currently listed as completed, categorized as an unspecified phase. The registered enrollment target is 594 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is Mayo Clinic, which has 2,844 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 1 intervention - of which PLD-Q is the first listed.
NCT02173080 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT02173080 about?
NCT02173080 is a clinical study titled "Development and Assessment of The Polycystic Liver Disease Questionnaire (PLD-Q).". This Pilot study will enable development \& assessment of a Polycystic Liver Disease-specific patient reported outcomes questionnaire (PLD-Q). Polycystic liver disease (PLD) is characterized by the formation of numerous cysts in the liver, and can lead to severe symptomatic hepatomegaly. It is commo...
What is the current status of trial NCT02173080?
This trial is currently completed. The enrollment target is 594 participants. The study started on 2014-06. Estimated completion is 2024-03-11.
What interventions are being tested in trial NCT02173080?
The interventions under investigation include: PLD-Q (OTHER).
Who is sponsoring clinical trial NCT02173080?
This trial is sponsored by Mayo Clinic, which has 2,844 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, the data changelog, or report a data error.